Renflexis
moderately to severely active ulcerative colitis moderately to severely active Crohn’s disease moderately to severely active rheumatoid arthritis plaque psoriasis psoriatic arthritis ankylosing spondylitis Renflexis is a biosimilar medication to Remicade. Renflexis blocks the action of the immune protein TNF-alpha. This helps to alleviate inflammation that causes symptoms. Renflexis is administered via infusion in three […]
Avsola
moderately to severely active ulcerative colitis moderately to severely active Crohn’s disease moderately to severely active rheumatoid arthritis psoriatic arthritis ankylosing spondylitis plaque psoriasis Avsola is a biosimilar to Remicade and works to block the action of TNF-alpha that influences the immune-mediated inflammation causing symptoms. Avsola is administered via infusion in three starting doses within […]
Remicade
Crohn’s disease ulcerative colitis moderately to severely active rheumatoid arthritis (RA) psoriatic arthritis psoriasis ankylosing spondylitis Remicade is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and severe or disabling plaque psoriasis in adults. Remicade is also used to treat ulcerative colitis and Crohn’s disease in adults and children at least 6 years old. […]
Inflectra
moderately to severely active ulcerative colitis moderately to severely active Crohn’s disease moderately to severely active rheumatoid arthritis psoriatic arthritis plaque psoriasis ankylosing spondylitis Inflectra is a biosimilar medication to Remicade. Inflectra works to block the action of the immune protein TNF-alpha that influences the inflammation that causes symptoms. Inflectra is administered via infusion, usually […]
